Abstract
We describe a case of poisoning with 3,4-methylenedioxymet-amphetamine Ecstasy that presented with all the features suggestive of a fatal outcome, including a creatinine phosphokinase level markedly higher than any previously reported. The patient, a paraplegic, was treated with dantrolene and made a full recovery.
This is a preview of subscription content, log in via an institution to check access.
References
Henry JA, Jeffreys KJ, Dawling S (1992) Toxicity and deaths from 3,4-methylenedioxymetamphetamine (“ecstasy”). Lancet 340:384–387
Bernard GR, Artigas A, Brigham KL (1994) The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Am J Respir Crit Care Med 149:818–824
Peroutka SJ (1987) Incidence of recreational abuse of 3,4-methylenedioxymetamphetamine (MDMA, “ecstasy”) on an undergraduate campus. N Engl J Med 317: 1542–1543
Henry JA (1992) Ecstasy and the dance of death. BMJ 305:5–6
Gordon CJ, Watkinson WP, O'Callaghan JP, Miller DB (1991) Effects of 3,4-methylenedioxymetamphetamine on autonomic thermoregulatory response of the rat. Pharmacol Biochem Behav 38:339–344
Screaton GR, Singer M, Cairns HS, Thrasher A, Sarner M, Cohen SL (1992) Hyperpyrexia and rhabdomyolysis after MDMA (“ecstasy”) abuse. Lancet 339:677–678
Larner AJ (1992) Complications of “ecstasy” misuse. Lancet 340:726
Tehan B, Hardern R, Bodenham A (1993) Hyperthermia associated with 3,4-methylenedioxymethamphetamine (‘eve’). Anaesthesia 48:507–510
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hall, A.P., Lyburn, I.D., Spears, F.D. et al. An unusual case of Ecstasy poisoning. Intensive Care Med 22, 670–671 (1996). https://doi.org/10.1007/BF01709744
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01709744